Yeah, the quality of the drug isn't the problem and I am sure it is worth some big money to another pharma. I just don't think another pharma will bid knowing the SGYP has some financial trouble. Not sure of the financing, whether they have covenants that keep them from dropping below a certain level. I wouldn't mind seeing some dilution just to give them a chance to increase sales. But dilution at 3.00 or less is not enough IMO. If they can shore up the cash, they can wait out an offer. There may be other ways out of this. I am not an expert but common sense tells me something has to happen soon. Still holding.
News 
Market Data 
Discover 
